Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07119372) titled 'Study of the Efficacy and Safety of BCD-131 and Mircera(R) in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Biocad
Condition:
Anemia
Chronic Kidney Disease
Chronic Kidney Disease Patients on Hemodialysis
Chronic Kidney Disease 5D
Intervention:
Biological: BCD-131 (pegdarbepoetin beta)
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: March 1, 2025
Target Sample Size...